Back to search

Article

Intratumoral Heterogeneity of Ki67 Proliferation Index Outperforms Conventional Prognostic Factors in Hormone Receptor-Positive Breast Cancer

2023-08-31

Abstract excerpt

<h4>Background: </h4> Immunohistochemistry (IHC) for ER, PR, HER2, and Ki67 is used in breast cancer (BC) pathology to assess tumor properties and predict patient outcomes and therapy responses. Visual scoring of the IHC biomarkers by pathologists, apart from reproducibility issues, does not sufficiently account for the intratumoral heterogeneity (ITH), often a subvisual feature within the tumor tissue. It has bee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2da312d3-72a9-5279-9eaa-8b622dbd9e1b
DOI
10.21203/rs.3.rs-3302114/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intratumoral Heterogeneity of Ki67 Proliferation Index Outperforms Conventional Prognostic Factors in Hormone Receptor-Positive Breast CancerDOI 10.21203/rs.3.rs-3302114/v1
Select a neighboring publication to make it the new centre.